UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061295
Receipt number R000070136
Scientific Title A Prospective Randomized Controlled Trial Comparing Implant Positioning Accuracy Between CT-Based Navigation Systems in Total Hip Arthroplasty
Date of disclosure of the study information 2026/05/01
Last modified on 2026/04/17 18:41:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of Two CT-Based Navigation Systems in Total Hip Arthroplasty

Acronym

THA-Navi Trial

Scientific Title

A Prospective Randomized Controlled Trial Comparing Implant Positioning Accuracy Between CT-Based Navigation Systems in Total Hip Arthroplasty

Scientific Title:Acronym

THA-Navi Trial

Region

Japan


Condition

Condition

Osteoarthritis of the hip, osteonecrosis of the femoral head, and femoral neck fracture

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the implant positioning accuracy between two CT-based navigation systems (Stryker and Nakashima Health Force) in total hip arthroplasty.

Basic objectives2

Others

Basic objectives -Others

No additional basic objectives are specified in this study.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Absolute error between planned and postoperative cup anteversion measured on CT within 2 weeks after surgery

Key secondary outcomes

Absolute error of cup inclination measured on CT within 2 weeks after surgery,
Femoral head center position,
Clinical outcomes (Modified Harris Hip Score),
Patient-reported outcomes (JHEQ, JOANR THA PROMs),
Postoperative complications


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Total hip arthroplasty will be performed using the Stryker CT-based navigation system. The navigation system will be used intraoperatively for implant positioning within the standard surgical procedure.

Interventions/Control_2

Total hip arthroplasty will be performed using the Nakashima Health Force CT-based navigation system. The navigation system will be used intraoperatively for implant positioning within the standard surgical procedure.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients scheduled for primary total hip arthroplasty,
Patients who provide written informed consent

Key exclusion criteria

Revision total hip arthroplasty,
Cemented cup cases,
Patients with prior pelvic osteotomy or pelvic trauma

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Yu
Middle name
Last name Takeda

Organization

Hyogo Medical University

Division name

Department of Orthopaedic Surgery

Zip code

663-8501

Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan

TEL

(0798)45-6452

Email

takeda.yu.0127@gmail.com


Public contact

Name of contact person

1st name Yu
Middle name
Last name Takeda

Organization

Hyogo Medical University

Division name

Department of Orthopaedic Surgery

Zip code

663-8501

Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo, Japan

TEL

(0798)45-6452

Homepage URL


Email

takeda.yu.0127@gmail.com


Sponsor or person

Institute

Hyogo Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, Hyogo Medical University

Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo, Japan

Tel

(0798)45-6164

Email

rss-adm@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学


Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 05 Month 01 Day

Date of IRB

2026 Year 07 Month 01 Day

Anticipated trial start date

2026 Year 07 Month 01 Day

Last follow-up date

2028 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 17 Day

Last modified on

2026 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070136